BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  Acura Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results

  July 31, 2012

   · 

  14 min read
• Business

  Agennix AG Reports Financial Results for Second Quarter and First Half of 2012

  July 31, 2012

   · 

  17 min read
• Drug Development

  La Jolla Pharmaceutical Company Announces FDA Agreement With Proposed Phase 1 Clinical Trial of GCS-100 in Chronic Kidney Disease

  July 31, 2012

   · 

  3 min read
• Lone Star Bio

  Xeris Pharmaceuticals Awarded Phase I-II NIH SBIR Fast Track Grant to Advance Stable, Non-Aqueous Glucagon for Bi-Hormonal Artificial Pancreas

  July 31, 2012

   · 

  1 min read
• Business

  Amarin Corporation PLC to Report Second Quarter 2012 Financial Results and Host Conference Call on August 8, 2012

  July 31, 2012

   · 

  1 min read
• Business

  Zogenix, Inc. Announces Conference Call and Webcast to Present Second Quarter 2012 Financial Results

  July 31, 2012

   · 

  1 min read
• Business

  ZELTIQ Aesthetics Announces Second Quarter 2012 Financial Results

  July 31, 2012

   · 

  1 min read
• BioMidwest

  Aastrom Biosciences, Inc. Announces Results of Common Stock Exchange for December 2010 Warrants

  July 31, 2012

   · 

  1 min read
• Business

  IMPAX Laboratories, Inc. Reports Second Quarter 2012 Adjusted EPS Increased to $0.60; GAAP EPS Increased to $0.27

  July 31, 2012

   · 

  1 min read
• Business

  Furiex Pharmaceuticals, Inc. Announces Closing of Priligy® Asset Transfer and License Agreements

  July 31, 2012

   · 

  1 min read